RISK FACTORS FOR PHENYTOIN TOXICITY
苯妥英中毒的危险因素
基本信息
- 批准号:6911550
- 负责人:
- 金额:$ 13.12万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-07-15 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This career development award is being sought by a doctoral-level clinical pharmacist nearing the completion of his PhD in Epidemiology who is fully committed to a career as an independent, federally-funded academic investigator in the pharmacoepidemiology of aging. The Candidate will use the proven "80% research / 20% clinical" career model, which will provide a source of clinical research questions as well as the infrastructure to conduct patient-oriented research. A three-phase career development plan has been formulated specifically to address gaps in the Candidate's background. In addition to the research project that will serve as the "core curriculum," the career development plan will further develop his focus on aging, and provide classroom and laboratory training in molecular and genetic epidemiology with the objective of enabling him to collaborative knowledgeably and effectively with laboratory scientists. In the latter phase of the award, the Candidate will develop additional research ideas, perform pilot studies, and apply for federal research (e.g., R01) funding. A formal career advisory process is an integral component of the career development plan. The research component of this proposal is a study of risk factors for severe neurologic phenytoin toxicity, which has been shown in multiple data sources to be one of the leading causes of serious adverse drug reactions, particularly in the elderly. The study will examine therapy- and patient-specific factors, including age and polymorphisms in the genes that express cytochrome P450 enzyme isoforms CYP2C19 and CYP2C9, which are responsible for phenytoin metabolism. The study design is a case-control study that is nested within the population of patients seen for seizure disorders within our health system. Concurrent surveillance in the three major hospitals in our health system will be used to identify potential cases, with controls being randomly selected from patients prescribed phenytoin for seizure disorders within our health system. This career development award will enable the Candidate to complete the development of the skills and experience that he will need to evolve into an independent academic investigator in the pharmacoepidemiology of aging.
这个职业发展奖是由一个接近完成流行病学博士学位的博士级临床药剂师寻求的,他完全致力于作为一个独立的,联邦政府资助的老龄化药物流行病学学术研究者的职业生涯。候选人将使用经过验证的“80%研究/ 20%临床”职业模式,这将提供临床研究问题的来源以及进行以患者为导向的研究的基础设施。为填补候选人背景方面的空白,专门制定了一个三阶段职业发展计划。除了将作为“核心课程”的研究项目外,职业发展计划将进一步发展他对老龄化的关注,并提供分子和遗传流行病学的课堂和实验室培训,目的是使他能够与实验室科学家进行知识和有效的合作。在该奖项的后一阶段,候选人将开发额外的研究思路,进行试点研究,并申请联邦研究(例如,R 01)资金。正式的职业咨询程序是职业发展计划的一个组成部分。本提案的研究部分是重度神经系统苯妥英毒性的风险因素研究,多个数据来源已显示其是严重药物不良反应的主要原因之一,尤其是在老年人中。该研究将检查治疗和患者特异性因素,包括年龄和表达细胞色素P450酶亚型CYP 2C 19和CYP 2C 9的基因多态性,这些基因负责苯妥英代谢。研究设计是一项病例对照研究,嵌套在我们卫生系统内因癫痫发作而就诊的患者人群中。我们的卫生系统中的三家主要医院的同步监测将用于识别潜在病例,对照组从我们卫生系统中的苯妥英治疗癫痫发作的患者中随机选择。这个职业发展奖将使候选人完成技能和经验的发展,他将需要发展成为一个独立的学术研究人员在药物流行病学的老化。
项目成果
期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inter-rater reliability of a classification system for hospital adverse drug event reports.
医院药品不良事件报告分类系统的评估者间可靠性。
- DOI:10.1038/sj.clpt.6100322
- 发表时间:2008
- 期刊:
- 影响因子:6.7
- 作者:Haynes,K;Hennessy,S;Morales,KH;Gibson,GA;Barnhart,C;Jaipaul,CK;Linkin,DR
- 通讯作者:Linkin,DR
Comparative cardiac safety of low-dose thioridazine and low-dose haloperidol.
低剂量硫利达嗪和低剂量氟哌啶醇的心脏安全性比较。
- DOI:10.1111/j.1365-2125.2004.02098.x
- 发表时间:2004
- 期刊:
- 影响因子:3.4
- 作者:Hennessy,Sean;Bilker,WarrenB;Knauss,JillS;Kimmel,StephenE;Margolis,DavidJ;Morrison,MaryF;Reynolds,RobertF;Glasser,DaleB;Strom,BrianL
- 通讯作者:Strom,BrianL
Disproportionality analyses of spontaneous reports.
自发报告的不成比例分析。
- DOI:10.1002/pds.995
- 发表时间:2004
- 期刊:
- 影响因子:2.6
- 作者:Hennessy,Sean
- 通讯作者:Hennessy,Sean
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Hennessy其他文献
Sean Hennessy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean Hennessy', 18)}}的其他基金
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
- 批准号:
10661090 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
- 批准号:
10501196 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
医疗补助人群中兴奋剂过量:谁有风险,何时有风险
- 批准号:
10662407 - 财政年份:2021
- 资助金额:
$ 13.12万 - 项目类别:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
医疗补助人群中兴奋剂过量:谁有风险,何时有风险
- 批准号:
10392130 - 财政年份:2021
- 资助金额:
$ 13.12万 - 项目类别:
Drug-Drug Interactions Involving Methadone and Buprenorphine
涉及美沙酮和丁丙诺啡的药物相互作用
- 批准号:
10436942 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
Enhancing the Utility of the Trend-in-Trend Research Design
增强趋势研究设计的实用性
- 批准号:
10017817 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
Drug-Drug Interactions Involving Methadone and Buprenorphine
涉及美沙酮和丁丙诺啡的药物相互作用
- 批准号:
10205012 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
Drug-Drug Interactions Involving Methadone and Buprenorphine
涉及美沙酮和丁丙诺啡的药物相互作用
- 批准号:
10649570 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
Enhancing the Utility of the Trend-in-Trend Research Design
增强趋势研究设计的实用性
- 批准号:
9813026 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
Enhancing the Utility of the Trend-in-Trend Research Design
增强趋势研究设计的实用性
- 批准号:
10162467 - 财政年份:2019
- 资助金额:
$ 13.12万 - 项目类别:
相似海外基金
Regulation and Consequences of Cytochrome P450 2E1
细胞色素 P450 2E1 的调节和后果
- 批准号:
10713697 - 财政年份:2023
- 资助金额:
$ 13.12万 - 项目类别:
Defining Structural and Functional Differences Between Cytochrome P450 11B1 and 11B2 Interactions with Redox Partner Adrenodoxin for Developing Cushing’s Disease and Primary Aldosteronism Treatments
定义细胞色素 P450 11B1 和 11B2 与氧化还原伙伴肾上腺素的相互作用在库欣病和原发性醛固酮增多症治疗中的结构和功能差异
- 批准号:
10536786 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Role of cytochrome P450 enzymes in pancreatic islets and diabetes pathophysiology
细胞色素 P450 酶在胰岛和糖尿病病理生理学中的作用
- 批准号:
572785-2022 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10704053 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Structure-Function of Insect Odorant-Binding Proteins and a Bacterial Cytochrome P450: Discovery of Mechanisms and Applications
昆虫气味结合蛋白和细菌细胞色素 P450 的结构功能:机制的发现和应用
- 批准号:
RGPIN-2020-05297 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Discovery Grants Program - Individual
LEAPS-MPS: Determining All the Contributions of Adrenodoxin to Cytochrome P450 Catalysis
LEAPS-MPS:确定肾上腺氧还蛋白对细胞色素 P450 催化的所有贡献
- 批准号:
2213207 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Standard Grant
Inter-Enzyme Crosstalk in the Cytochrome P450 Ensemble: Implications for the Effects of Alcohol on Drug Metabolism and Alcohol-Drug Interactions
细胞色素 P450 整体中的酶间串扰:酒精对药物代谢和酒精-药物相互作用影响的影响
- 批准号:
10445619 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Role of cytochrome P450 enzymes in pathogenesis of cardiac hypertrophy in different sexes
细胞色素P450酶在不同性别心肌肥厚发病机制中的作用
- 批准号:
475633 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Studentship Programs
Defining Structural and Functional Differences Between Cytochrome P450 11B1 and 11B2 Interactions with Redox Partner Adrenodoxin for Developing Cushing’s Disease and Primary Aldosteronism Treatments
定义细胞色素 P450 11B1 和 11B2 与氧化还原伙伴肾上腺素的相互作用在库欣病和原发性醛固酮增多症治疗中的结构和功能差异
- 批准号:
10685280 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别:
Structure-Function Studies of the Human Cytochrome P450 27 Family
人类细胞色素 P450 27 家族的结构功能研究
- 批准号:
10797727 - 财政年份:2022
- 资助金额:
$ 13.12万 - 项目类别: